Valeant Pharma (VRX) TRx Shows Big Upswing in Week 1 of Walgreen's (WBA) Agreement - Evercore ISI
Tweet
Share
E-mail
Get Alerts VRX Hot Sheet
Price: $23.40 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 2
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 2
Join SI Premium – FREE
Evercore ISI analyst Umer Reffat is noting a strong first week for the Valeant Pharma (NYSE: VRX)/Walgreens (NYSE: WBA) deal.
The chart below shows a sharp move in TRx for all Valeant products under the agreement. The biggest drivers, according to Raffat, were: Jublia, Solodyn, Onexton, Luzu and Retin-A Micro.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Tesla (TSLA) soars on Q1 print
- Lockheed Martin (LMT) PT Raised to $480 at Wells Fargo
Create E-mail Alert Related Categories
Analyst Comments, Hot Comments, Short Sales, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
